Will you have Skin cancer - melanoma when taking Impatiens capensis and N-a-g - from FDA reports
There is no Skin cancer - melanoma reported by people who take Impatiens capensis and N-a-g yet. This review analyzes which people have Skin cancer - melanoma with . It is created by eHealthMe based on reports from FDA, and is updated regularly.
eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.
eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.
The information that eHealthMe collects includes:
- Side effects (including severity and how people recover from them)
- Associated conditions or symptoms
- Drug effectiveness
- Demographic data regarding drug use
How the study uses the data?
The study is based on jewelweed and n - acetyl glucosamine (the active ingredients of Impatiens capensis and N-a-g, respectively), and Impatiens capensis and N-a-g (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Skin cancer - melanoma are also considered in the study.
What is Impatiens capensis?
Impatiens capensis has active ingredients of jewelweed.
What is N-a-g?
N-a-g has active ingredients of n - acetyl glucosamine. (latest outcomes from N-a-g 1 users)
What is skin cancer - melanoma?
Skin cancer - melanoma (cancer of skin melanine) has been reported by people with sleep disorder, melanoma, muscle spasms, muscle aches, parkinson's disease (latest reports from 50 Skin cancer - melanoma patients).
How to use the study?
Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.
Do you take Impatiens capensis and N-a-g?
- Personalize this study to your gender and age
- Subscribe to monitor Impatiens capensis and N-a-g
- Subscribe to monitor Impatiens capensis
- Subscribe to monitor N-a-g
You are not alone:
- Connect with people like you who take Impatiens capensis and N-a-g
- Use your healthcare experience to help people like you, and be rewarded
Drugs that are associated with Skin cancer - melanomaSkin cancer - melanoma
Could your condition cause Skin cancer - melanomaSkin cancer - melanoma
What would happen?
Recent general studies
- Will you have Consciousness - Decreased with Abilify? - now
- Will you have Stuporous with Abilify? - now
- Will you have Obtundation with Abilify? - now
- Will you have Mental Status - Decreased with Abilify? - a second ago
- Will you have Loss Of Alertness with Abilify? - a second ago
- What to expect when you take Provigil and Symmetrel - 2 seconds ago
- Botox and Early Fumitory drug interaction - 3 seconds ago
- Men aged 40-49 who have Pseudomembranous Colitis with Fosamax - 5 seconds ago
- Xifaxan and Cefzil drug interaction - 9 seconds ago
- Accuretic vs. Tiazac - 12 seconds ago
Recent personal studies
- A study for a 74 year old man who takes Cozaar - 4 hours ago
- A study for a 58 year old woman who takes Stiolto Respimat - 4 hours ago
- Prediction of Ativan for a 46 year old woman - 5 hours ago
- A study for a 62 year old woman who takes Labetalol Hydrocloride - 5 hours ago
- Drug comparison of Prednisolone Acetate, Azithromycin, Omeprazole for a 53 year old woman - 8 hours ago
- A study for a 73 year old woman who takes Vitamin B12 - 8 hours ago
- Prediction of Depakote for a 36 year old man - 9 hours ago
- A study for a 52 year old woman who takes Lisinopril - 11 hours ago
- A study for a 68 year old woman who takes Benlysta, Plaquenil, Cellcept - 15 hours ago
- A study for a 50 year old man who takes Symbicort, Singulair - 21 hours ago
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.